Startups
Edit
Nightstar
http://www.nightstarx.com/Last activity: 05.03.2019
Active - Reference to Biogen Idec
Overview
Employees
11-50
Total raised
$80M
Founded date
2014
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Nov 10, 2015 | Series B round | $35M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 6, 2017 | UK-based biotech firm Nightstar raises $45 million Series C | London-based Nightstar, a company that develops treatments for retinal diseases, raised $45 million in funding from several investors including Wellington Management Company, Redmile Group, Syncona, and New Enterprise Associates in a Series... |
| Jul 5, 2017 | Term Sheet — Wednesday, July 5 | Welcome back from the holiday weekend. Like many of you, my days off were peppered with a slew of push notifications about the sexual harassment reckoning happening in Startup-land. I felt disgusted by every new accusation. But I also felt ... |
| Jul 5, 2017 | Nightstar Closes $45M Series C Funding | Nightstar, a London, UK-based retinal gene therapy company, closed a $45m Series C funding. Backers included Wellington Management Company, Redmile Group, Syncona and New Enterprise Associates. The company intends to use the funds for the u... |
| Jun 29, 2017 | NEA Leads $45M Series C for NightstaRx | BOSTON & LONDON--(BUSINESS WIRE)--NightstaRx Limited, a late-stage biopharmaceutical company developing gene therapies for inherited retinal diseases, today announced the completion of a $45 million Series C financing transaction. New i... |
| Jun 29, 2017 | NightstaRx Raises $45 Million Series C | BOSTON & LONDON--(BUSINESS WIRE)--NightstaRx Limited, a late-stage biopharmaceutical company developing gene therapies for inherited retinal diseases, today announced the completion of a $45 million Series C financing transaction. New i... |
| Nov 10, 2015 | NightstaRx Raises $35M in Series B Financing | NightstaRx Ltd, a London, UK-based biopharmaceutical company specializing in developing gene therapies for inherited retinal dystrophies, raised $35m in Series B financing. The round was led by New Enterprise Associates (NEA), with particip... |
Reviews 0
FAQ about Nightstar
When was Nightstar founded?
Nightstar was founded in 2014.
How much funding has Nightstar raised?
Nightstar has raised $80M in total across 2 funding rounds.
What funding rounds has Nightstar raised?
Parsers VC lists 2 funding rounds of Nightstar, among them a Series B round of $35M on Nov 10, 2015.
What has the press written about Nightstar?
Parsers VC has collected 7 articles mentioning Nightstar, among them “UK-based biotech firm Nightstar raises $45 million Series C” (Jul 6, 2017) and “Term Sheet — Wednesday, July 5” (Jul 5, 2017).
Is Nightstar still active?
Yes, Nightstar is active; its latest activity on Parsers VC dates from Mar 5, 2019.